Dr. Wagner is a clinical nephrologist. He is the Director of the Kidney Institute of New Mexico as well as being the acting Associate Chief of Research and Renal Section Chief for the VA in Albuquerque.

This is the second time Dr. Wagner has been on the podcast with his research team. In this episode we re-examine the mechanisms behind gadolinium retention and receive updates on new discoveries.

To fund Dr. Wagner’s work you can donate to the Kidney Institute of New Mexico at

https://www.unmfund.org/fund/unm-kidney-institute-of-new-mexico/

Links:

Reveal Pharmaceuticals, Gadolinium-free MRI contrast agents products.

http://www.revealpharma.com


The FDA adverse event reporting system

https://open.fda.gov/data/faers/


Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378745/

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Andrew Scarborough. Innehållet i podden är skapat av Andrew Scarborough och inte av, eller tillsammans med, Poddtoppen.